IP Library Patent Application 12906166
Patent Application
App. No. 12/906,166

BIOMARKER STABILIZING AGENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/906,166
Abstract

Biomarker stabilizing agents. In at least one embodiment of a stabilizing bead of the present disclosure, the stabilizing bead comprises a latex particle having a carboxylate group, and a stabilizing agent functionally coupled to the latex particle, wherein the stabilizing agent is capable of completely or substantially preventing the degradation or inactivation of a diagnostic agent in close proximity to the stabilizing agent. Optionally, an embodiment of a stabilizing bead may further comprise at least one of human serum albumin (HSA) and bovine serum albumin (BSA). Moreover, an embodiment of a stabilizing bead of the present disclosure may further comprise a linker group coupled to latex particle.

Claims (12)

1 . A stabilizing bead comprising:

a latex particle having a carboxylate group; and

a stabilizing agent functionally coupled to the latex particle, wherein the stabilizing agent is capable of completely or substantially preventing the degradation or inactivation of a diagnostic agent in close proximity to the stabilizing agent.

2 . The stabilized bead of claim 1 , further comprising at least one of human serum albumin (HSA) and bovine serum albumin (BSA).

3 . The stabilizing bead of claim 1 , further comprising a linker group coupled to latex particle.

4 . The stabilizing bead of claim 3 , wherein the linker group comprises a maleimide compound.

5 . The stabilizing bead of claim 4 , wherein the maleimide compound is selected from the group consisting of Succinimidyl 4-[N-Maleimidomethyl]Cyclohexane-1-Carboxylate (SMCC) and N-Hydroxysuccinimide-activated hexa(ethylene glycol)undecane Thiol (NHS).

6 . The stabilizing bead of claim 4 , wherein the linker group is coupled to the HSA or BSA.

7 . The stabilizing bead of claim 1 , further comprising an antibody functionally linked to the latex particle.

8 . The stabilizing bead of claim 1 , wherein the latex particle has a diameter of about 0.02 μm to about 7.0 μm.

9 . The stabilizing bead of claim 1 , wherein the stabilizing agent is selected from the group consisting of Fixanal® Buffer 6.0 (Sigma-Aldrich Co.), acetic acid, aluminum hydroxide bentonite, aluminum sulfate hydrate, aluminum potassium sulfate dodecahydrate, benzoic acid, caffeine, and 3-tert-butyl-hydroxyanisole, or a combination thereof.

10 . The stabilizing bead of claim 1 , wherein the stabilizing agent comprises a plurality of stabilizing agents each present in approximately the same concentration.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2014
From: COMPANION DIAGNOSTICS, INC.
To: BMO HARRIS BANK N.A.
Reel/Frame 032597/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2013
From: SELINFREUND, RICHARD H.; VIG, RAKESH; GILL, RICHARD P.
To: COMPANION DIAGNOSTICS INC.
Reel/Frame 029890/0026 →